- Home
- PSEC vs BLFS Comparison
PSEC vs BLFS Comparison
Compare PSEC & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSEC
- BLFS
- Stock Information
- Founded
- PSEC 2004
- BLFS 1987
- Country
- PSEC United States
- BLFS United States
- Employees
- PSEC N/A
- BLFS N/A
- Industry
- PSEC Finance/Investors Services
- BLFS Medical/Dental Instruments
- Sector
- PSEC Finance
- BLFS Health Care
- Exchange
- PSEC Nasdaq
- BLFS Nasdaq
- Market Cap
- PSEC 1.2B
- BLFS 1.3B
- IPO Year
- PSEC 2004
- BLFS 1989
- Fundamental
- Price
- PSEC $2.79
- BLFS $28.04
- Analyst Decision
- PSEC Sell
- BLFS Strong Buy
- Analyst Count
- PSEC 1
- BLFS 7
- Target Price
- PSEC $2.50
- BLFS $30.86
- AVG Volume (30 Days)
- PSEC 3.4M
- BLFS 372.3K
- Earning Date
- PSEC 11-07-2025
- BLFS 11-06-2025
- Dividend Yield
- PSEC 19.64%
- BLFS N/A
- EPS Growth
- PSEC N/A
- BLFS N/A
- EPS
- PSEC N/A
- BLFS N/A
- Revenue
- PSEC $719,436,000.00
- BLFS $93,468,000.00
- Revenue This Year
- PSEC N/A
- BLFS $25.65
- Revenue Next Year
- PSEC N/A
- BLFS $14.81
- P/E Ratio
- PSEC N/A
- BLFS N/A
- Revenue Growth
- PSEC N/A
- BLFS 68.16
- 52 Week Low
- PSEC $2.57
- BLFS $19.10
- 52 Week High
- PSEC $5.33
- BLFS $29.62
- Technical
- Relative Strength Index (RSI)
- PSEC 53.52
- BLFS 57.51
- Support Level
- PSEC $2.68
- BLFS $26.74
- Resistance Level
- PSEC $2.81
- BLFS $29.57
- Average True Range (ATR)
- PSEC 0.07
- BLFS 1.06
- MACD
- PSEC 0.00
- BLFS 0.04
- Stochastic Oscillator
- PSEC 66.67
- BLFS 57.02
About PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.